Theralase Technologies (TSXV:TLT) Sale Of Investment : C$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Sale Of Investment?

Theralase Technologies's sale of investment for the three months ended in Dec. 2024 was C$0.00 Mil. It means Theralase Technologies gained C$0.00 Mil from selling investments. Theralase Technologies's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Sep. 2024 ), Theralase Technologies gained the same money from selling investments in Dec. 2024 (C$0.00 Mil).

Theralase Technologies Sale Of Investment Historical Data

The historical data trend for Theralase Technologies's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Sale Of Investment Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Sale Of Investment

Get a 7-Day Free Trial

Theralase Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Theralase Technologies Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Theralase Technologies Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

TLTFF:USA TTX:Germany

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Executives

Matthew Thomas Perraton	Director
Roger John Dumoulin-white	10% Security Holder, Director, Senior Officer
Kristina Maria Hachey	Senior Officer
Arkady Mandel	Senior Officer
Guy John Anderson	Director
Shawn Shirazi	Senior Officer